Entewell 0.5 Tablet
Marketer
Jasgur Life Sciences
Salt Composition
Entecavir (0.5mg)
Overview Entewell 0.5 Tablet
Hepatitis B (HBV) infection is treated with the antiviral medication entecavir. Its mechanism involves blocking viral reproduction, consequently lowering HBV levels within the body. This suppression of viral replication mitigates liver damage progression. Administer Entewell 0.5mg tablets on an empty stomach, adhering strictly to your physician's prescribed dosage and duration. Consistent, timely intake maximizes efficacy, promoting improved liver function and reducing the risk of complications from chronic HBV. The effect of Entewell 0.5mg tablets on liver cancer or cirrhosis risk from chronic HBV remains undetermined. Maintain consistent medication use until medically advised to discontinue. Headache, nausea, vomiting, abdominal pain, tiredness, and diarrhea are common, usually mild side effects. Report persistent or bothersome symptoms to your doctor. Rarely, skin reactions or liver injury may occur, necessitating close physician monitoring, especially initially. Disclose any pre-existing skin conditions or kidney disease before commencing treatment. Regular blood tests to monitor blood cell counts and liver function are typically required during treatment. Alcohol consumption should be avoided due to increased liver damage risk. Consult your physician before use during pregnancy or breastfeeding. If HIV-positive, abstain from unprotected sex and sharing personal items like razors or toothbrushes; discuss safe sex practices, including condom use, with your doctor to prevent HIV transmission.
Uses of Entewell 0.5 Tablet
Persistent infection with the hepatitis B virus (HBV)
Major Benefits of Entewell 0.5 Tablet:
Consume this medication according to your physician's prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Entewell 0.5 Tablet on an empty stomach.
Common Side effects of Entewell 0.5 Tablet:
- Headache
- Nausea
- Vomiting
- Fatigue
- Stomach pain
- Diarrhea
How to use Entewell 0.5 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Entewell 0.5 Tablet on an empty stomach.
How Entewell 0.5 Tablet works:
Virex 0.5mg tablets offer antiviral action. They inhibit viral replication within human cells, thus halting further viral production and resolving the infection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Entewell 0.5 Tablet may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Entewell 0.5 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Entewell 0.5 Tablet use may pose a risk. Available data suggest potential transfer to breast milk, with possible adverse effects for the infant.
DrivingUNSAFE
Taking Entewell 0.5 Tablet may cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Entewell 0.5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
For patients with hepatic impairment, Entewell 0.5 mg tablets are considered safe and do not require dosage modification.
What if you forget to take Entewell 0.5 Tablet :
Should you forget a dose of Entewell 0.5 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Entewell 0.5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Analogous nucleoside |
| Developing Good Habits | No. |
| Treatment Category | Antimicrobials |
| Action Class | Reverse transcriptase inhibitors (RTIs) that are nucleosides or nucleotides |




